Table 1

Evolution of children with Kawa-COVID-19 1 month after disease onset in one Great Paris Region tertiary centre, n=8

	Patient 1	Patient 2	Patient 3	Patient 4	Patient 5	Patient 6	Patient 7	Patient 8
Age (years)	15	12	11	11	13	6	14	10
Sex	Male	Female	Male	Female	Female	Male	Female	Female
Type of Kawasaki disease	Incomplete	Incomplete	Complete	Complete	Complete	Incomplete	Complete	Incomplete
SARS-CoV-2 nasopharyngeal RT-PCR	Negative	Positive	Positive	Positive	Positive	Negative	Positive	Negative
SARS-CoV-2 serology	IgG+	IgG+	IgG+	Negative	IgG+	IgG+	IgG+	IgG+
Cardiac involvement	Myocarditis and coronary dilatation (Z score=4)	None	None	Myocarditis	Myocarditis and coronary dilatation (Z score=4)	Myocarditis	Myocarditis	Myocarditis
Haemodynamic support	Yes	No	No	No	Yes	Yes	Yes	Yes
Ferritinaemia at diagnosis (microG/L)	1221	2500	768	118	1208	222	207	917
Maximal CRP level (mg/L)	309	258	179	119	352	369	316	444
Treatments	IVIG +mPDN	IVIG +mPDN	No	IVIG	IVIG +tocilizumab	IVIG +mPDN	IVIG	IVIG +mPDN
Evolution after 1 month
Clinical assessment	Normal	Normal	Normal	Normal	Normal	Normal	Normal	Normal
CRP level (mg/L)	<10	<10	<10	<10	<10	<10	<10	<10
Cardiac ultrasound	Normal	Normal	Normal	Normal	Normal	Normal	Normal	Normal

CRP, C-reactive protein; IVIG, intravenous immunoglobulins; mPDN, methylprednisolone; RT-PCR, real-time PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.